Stock price when the opinion was issued
All the insurance names, both in Canada and the US, continue to work. If interest rates do, in fact, go higher, that will only be beneficial for lifecos and other insurers. The chart looks fantastic. Good run, so there is some weakening in the intermediate term.
If a long-term holding, best thing you can do is sit on your hands and do nothing except participate in the DRIP program. Especially if he's right on the broader call of rates being 8-10% in the secular bear market of 2030-40, should be a big tailwind for insurers.
For income-oriented investors. Mature market focus in Canada, US, and mature parts of Europe; whereas MFC and SLF are pursuing growth more in EMs. Better on capital allocation, likes growth potential. Trades at less than 10x earnings. Attractive yield of 5.2%.
(Analysts’ price target is $44.20)